FDA, CBP seize 3 million illegal e-cigarette products worth $76 million, including GEEKBAR

Oct.23.2024
FDA, CBP seize 3 million illegal e-cigarette products worth $76 million, including GEEKBAR
The U.S. FDA and Customs and Border Protection (CBP) conducted a joint operation that resulted in the seizure of approximately 3 million unauthorised e-cigarette products with an estimated retail value of $76 million, marking the FDA's largest seizure to date. Notably, GEEKBAR was the only e-cigarette brand mentioned in the report.

The US Food and Drug Administration (FDA) announced on its website on 22 October that it had worked with US Customs and Border Protection (CBP) to administratively seize approximately 3 million unapproved e-cigarette products with an estimated retail value of $76 million. Notably, GEEKBAR was the only e-cigarette brand mentioned in the report.

 

This seizure was part of a joint operation in July to inspect inbound shipments to prevent illegal e-cigarettes from entering the U.S. It is the largest enforcement action by the FDA to date.
 

FDA, CBP seize 3 million illegal e-cigarette products worth $76 million, including GEEKBAR
The FDA has seized illegal e-cigarettes, including GEEKBAR. | Image source: FDA official website

 

The FDA and the US Department of Justice (DOJ) announced in June the creation of a joint federal task force to crack down on the illegal distribution and sale of e-cigarettes.

 

The FDA revealed that the joint team spent several months conducting extensive investigations in preparation for the operation. This included reviewing shipping invoices, identifying potentially illegal imports and gathering intelligence, all of which contributed to the success of the operation.

 

During inspections of goods arriving from China, the team uncovered numerous unauthorised e-cigarettes, including brands such as GEEKBAR. Many of these products were deliberately mis-declared as unrelated items and undervalued to avoid customs duties and detection. The seized products will now be processed in accordance with US Customs and Border Protection (CBP) regulations.

 

"The FDA is on high alert and coordinating closely with our federal partners to stop these products at the border. Many of these e-cigarettes end up in the hands of children, and the newly formed federal task force is committed to working together to combat this unethical behaviour," said FDA Commissioner Robert M. Califf.

 

Troy A. Miller, a senior official with U.S. Customs and Border Protection, reiterated the agency's commitment to protecting American consumers. "CBP places a high priority on intercepting illegal products that could cause harm. We will continue to work with our law enforcement partners to identify and seize unsafe and illegal goods."

 

"This is not our first joint seizure operation, and it certainly won't be the last. We are committed to tracking down those who attempt to smuggle illegal e-cigarettes. The fact that these criminals essentially threw $76 million in the trash should remind them that their time and money would be better spent complying with the law," said Brian King, director of the FDA's Center for Tobacco Products. 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Imperial Brands Explains What the UK Tobacco and Vapes Act 2026 Means for Retailers
Imperial Brands Explains What the UK Tobacco and Vapes Act 2026 Means for Retailers
Imperial Brands has outlined what the newly approved UK Tobacco and Vapes Act 2026 means for retailers. The legislation received Royal Assent on April 29, 2026, and gives the Government powers to extend tobacco-style regulation to a wider range of products, including vaping products, heated tobacco, nicotine pouches and cigarette papers. Imperial Brands emphasized that most measures will be introduced in phases rather than taking effect immediately.
May.11 by 2FIRSTS.ai
Vapesourcing Lists RELX Creator Pro 15K as “Coming Soon,” Shows U.S. Warehouse Shipping Options
Vapesourcing Lists RELX Creator Pro 15K as “Coming Soon,” Shows U.S. Warehouse Shipping Options
2Firsts found that U.S.-facing and cross-border vape retailer Vapesourcing has created a product page for the “RELX Creator Pro 15K Disposable Vape Kit 3%,” marked as “Coming Soon.” The page lists U.S. warehouse shipping options, but does not show that the product is currently available for purchase.
Market
Jun.08
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts held a UK vape duty stamp compliance exchange in Shenzhen on May 14, bringing together representatives from nearly 20 companies. The session addressed Vaping Products Duty, duty stamp applications, UK agency qualifications and warehousing, while introducing 2Firsts Compliance Solutions’ UK service.
Events
May.17
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
A report by KFF Health News says that as the Trump administration pursued a series of policies favorable to the nicotine and tobacco industry, President Donald Trump increased his holdings in tobacco companies while benefiting from substantial industry-linked political donations, prompting questions from public health advocates about potential conflicts of interest and regulatory direction.
Jun.12
Imperial Brands Launches 2ml+10ml blu MAX 6000 Vape System
Imperial Brands Launches 2ml+10ml blu MAX 6000 Vape System
mperial Brands has launched blu MAX 6000 in the UK, positioning the product as a higher-puff vape kit with longer-lasting use and replaceable pod+refill options. The device uses a 2ml+10ml click-on box format, with starter kits priced at £10.99 (approximately $14) and replacement pod+refill packs priced at £7.99 (approximately $10).
Market
May.19
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai